Lenalidomide is a dicarboximide that consists of 1-oxoisoindoline bearing an amino substituent at position 4 and a 2,6-dioxopiperidin-3-yl group at position 2. Inhibits the secretion of TNF-alpha. Among its listed roles, it functions as a angiogenesis inhibitor, an antineoplastic agent and an immunomodulator. It belongs to the class of isoindoles, a dicarboximide, a member of piperidones and an aromatic amine. It is grouped under the following drug class(es): Immunosuppressants. Its therapeutic use is listed as anti-cancer agents and antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Revlimid and Revimid. Its PubChem CID is 216326.
Lenalidomide
| CAS No | 191732-72-6 |
|---|---|
| Molecular Formula | C13H13N3O3 |
| Molecular Weight | 259.26 g/mol |
| Synonyms | 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lenalidomide is a dicarboximide that consists of 1-oxoisoindoline bearing an amino substituent at position 4 and a 2,6-dioxopiperidin-3-yl group at position 2. Inhibits the secretion of TNF-alpha.
The listed CAS number is 191732-72-6.
The listed molecular formula is C13H13N3O3.
The listed molecular weight is 259.26 g/mol.
3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione.
The source lists Revlimid and Revimid.